Neo Protifed

Quick links to important sections

Neo Protifed

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Neo Protifed

Quick Facts

Property Description
Active Ingredient Pseudoephedrine and Triprolidine
Form Oral Tablet, Oral Syrup/Liquid
Pharmacological Class Antihistamine/Nasal Decongestant Combination
Common Use Symptomatic relief of respiratory and allergic issues
Origin Synthetic chemical compounds

What Type of Medicine is Neo Protifed?

Neo Protifed is defined as a fixed-dose combination medication belonging to the therapeutic category of an Antihistamine/Nasal Decongestant Combination. This oral drug is supplied for administration primarily as a solid oral tablet or as an oral syrup or liquid product. The product is clinically recognized for its utility in addressing two distinct symptom pathways related to upper respiratory conditions and allergies, confirmed by clinical reviews on its dual-action effectiveness.

This dual approach is crucial to its identity, offering a broader scope of symptomatic management compared to single-ingredient treatments, which may focus only on either congestion or allergic reaction. For instance, in a typical use scenario like experiencing hay fever, Neo Protifed targets both the itchiness caused by histamine and the stuffy nose caused by inflammation.

Composition and Origin: Pseudoephedrine and Triprolidine

The product's efficacy rests on its two active ingredients, which are both synthetic chemical substances: Pseudoephedrine hydrochloride and Triprolidine hydrochloride. Pseudoephedrine is classified as a sympathomimetic amine, which functions as the nasal decongestant component. Triprolidine is a first-generation histamine H1 antagonist, belonging to the alkylamine chemical class.

The Pseudoephedrine component achieves its action through vasoconstriction (narrowing of blood vessels), thereby reducing swelling in the nasal and sinus tissues. The Triprolidine component operates by competitively blocking H1-receptor sites, a mechanism pharmacological studies have confirmed is effective in diminishing allergic symptoms. The final drug product is formulated using either a solid matrix or an aqueous syrup vehicle, with the liquid form often positioned for pediatric patients or those who have difficulty swallowing tablets.

Regulatory References

  1. Triprolidine and Pseudoephedrine - DailyMed

What side effects are possible with Neo Protifed?

Possible Side Effects and Safety Information

The official safety documentation for Neo Protifed, a combination of Pseudoephedrine and Triprolidine, classifies possible side effects based on frequency and affected body system. Adverse reactions are primarily grouped under Nervous System Disorders, Gastrointestinal Disorders, and Cardiac Disorders.

Frequency-Classified Adverse Reactions

Classification Examples of Officially Listed Effects
Common Dry mouth, somnolence, headache, nausea, vision blurred.
Very Rare Cerebrovascular accident, myocardial infarction, ischaemic colitis, dysuria.
Not Known High anion gap metabolic acidosis, ischaemic optic neuropathy.

Serious Safety Considerations

Regulatory labels document rare but clinically significant adverse reactions. These include severe dermatological reactions like Acute Generalised Exanthematous Pustulosis (AGEP), Stevens-Johnson syndrome (SJS), and Toxic Epidermal Necrolysis (TEN). Serious cardiovascular events, such as myocardial infarction and arrhythmia, are also officially listed.

Population-Specific Notes and Constraints

The safety profile includes specific considerations for certain patient groups. Older adults may be more susceptible to confusion or paradoxical excitation. The label notes that misuse in infants may be fatal. Additionally, the medicine is generally Contraindicated in severe renal impairment. The development of specific serious symptoms, such as sudden vision loss (ischaemic optic neuropathy) or signs of ischaemic colitis, requires immediate regulatory-mandated cessation of use.

Overdose and Emergency Response

Overdose involving Neo Protifed is defined by the toxic effects of its components, requiring specific emergency measures as documented in regulatory labeling. The recognized clinical signs often present as both Central Stimulant Effects and Anticholinergic Toxicity.

Documented Overdose Manifestations

Manifestations may include extreme nervousness, agitation, insomnia, tremor, and confusion, alongside cardiovascular symptoms like tachycardia (fast heartbeat) and hypertension. Anticholinergic signs can involve difficulty with urination (urinary retention) and dry mouth. Accidental overdose has been associated with severe outcomes in very young children.

Serious Risks and Emergency Actions

Overdose may escalate to life-threatening outcomes, including seizures (epileptiform convulsions), loss of consciousness, and respiratory depression (trouble breathing). Severe vascular events, such as Ischaemic colitis and Posterior Reversible Encephalopathy Syndrome (PRES), are officially documented complications. The risk for such neurological events is increased in individuals with severe or uncontrolled high blood pressure or severe chronic kidney disease.

Regulatory guidance mandates that immediate medical assistance must be sought for any suspected overdose. Emergency services (911) must be called immediately if the person has collapsed, had a seizure, or has trouble breathing. Treatment is symptomatic and supportive, as no specific antidote is officially documented. Consultation with a poison control center is also required.

Therapeutic Uses of Neo Protifed

This combination is commonly used to help with symptoms related to upper respiratory allergies, the common cold, hay fever, and perennial rhinitis. The medication is applied in clinical settings that involve acute or unstable symptom patterns, offering supportive symptomatic assistance.


Dual Relief for Allergic Symptoms

This therapeutic domain is relevant in conditions characterized by periods of heightened allergic responses. It helps address symptom clusters that may become intense or disruptive, such as sneezing, itchy eyes, and noticeable runny nose, offering symptomatic relief that helps maintain a sense of stability when symptoms are more noticeable.


Management of Nasal and Sinus Congestion

Neo Protifed is commonly used to help with conditions presenting with symptoms related to heightened physiological activity in the nasal and sinus passages, including the common cold and non-allergic breathing illnesses. It is applied in addressing symptoms related to physical discomfort like stuffy nose, physical obstruction, and pressure, contributes to easing the overall symptom load during phases when supportive symptom management is appropriate.


Property Description
Quick Fact Contributes to easing Symptoms related to Congestion and Allergic Irritation

Regulatory References

  1. NIH's National Library of Medicine

Eligibility and Restrictions for Use

Official Eligibility Profile: Neo Protifed

The eligibility and non-eligibility information for a medicine is strictly defined by government regulatory agencies (such as the FDA, EMA, Health Canada, etc.) in official prescribing documents (e.g., Prescribing Information or Summary of Product Characteristics). These documents formalize the populations who are allowed to use the drug, those for whom use is restricted, and those for whom use is formally contraindicated.

Regulatory Status and Eligibility Constraints

A comprehensive search of authoritative governmental drug approval databases and public drug formularies did not identify an official regulatory record for a product named Neo Protifed. The absence of official documentation means that no government-verified eligibility profile exists for this specific name.

Therefore, the following key eligibility classifications have not been officially established or documented by regulatory authorities:

  • Formal Contraindications: No official regulatory contraindications are published.
  • Age-Related Eligibility: No official rules define eligibility or non-eligibility for pediatric, adolescent, or geriatric groups.
  • Conditional Use Groups: No official restrictions based on comorbidities (such as severe renal or hepatic impairment) are documented.
  • Pregnancy and Lactation: No official regulatory status regarding use during pregnancy or breastfeeding is documented.

Connection to the overall eligibility profile

Because no official prescribing label or monograph for Neo Protifed is found in regulatory databases, there is no governmental statement that officially defines who can or who cannot use the medicine. The official regulatory status is that this product's eligibility profile is not formally documented by major health authorities.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section describes the officially documented interaction patterns for Neo Protifed (Pseudoephedrine and Triprolidine) as established by government regulatory bodies.

Formal Contraindicated Combinations

Co-administration with Monoamine Oxidase Inhibitors (MAOIs) is strictly contraindicated due to the risk of severe hypertensive crisis (a rapid and dangerous rise in blood pressure). The restriction includes use concurrently or within two weeks (14 days) of discontinuing MAOI treatment. Co-administration with Other Sympathomimetic Agents or certain Beta-Blockers is also prohibited in official labeling due to the potential for additive cardiovascular effects.


Clinically Significant Pharmacodynamic Interactions

Interactions affecting the central nervous system (CNS) are documented due to the Triprolidine component. Co-administration with Central Nervous System (CNS) Depressants may enhance the sedative effects and increase drowsiness. Patients are advised to avoid alcohol (Ethanol) as it may increase this sedative effect. The Pseudoephedrine component may officially diminish the antihypertensive effects of medicinal products like Guanethidine and Methyldopa.


Other Documented Restrictions

Alkalinizing Agents may increase the serum concentration of Pseudoephedrine due to interference with elimination, a pharmacokinetic effect. Furthermore, individuals with Severe Renal or Hepatic Impairment are noted in labeling as potentially experiencing increased effects of the medicine due to slower clearance, thereby heightening interaction severity.

Mechanism of Action

How Neo Protifed Works

Regulation of Nasal Vascular Tone

This primary mechanism is driven by Pseudoephedrine, which acts as an agonist on the alpha-1 adrenergic receptors (alpha1) found on blood vessels in the nasal lining. Activation of these receptors promotes vasoconstriction, actively reducing blood flow and the volume of blood pooled in the tissue. This targeted action is fundamental to promoting the reduction of tissue volume derived from vasoconstriction and modulates sympathetic pathway signaling in the upper airways.


Competitive Blockade of Histamine H1 Signaling

The second key action involves Triprolidine, which functions as a competitive antagonist at the Histamine H1 receptors. By physically blocking these receptor sites, the drug prevents the endogenous mediator histamine from initiating its signaling cascade. This mechanism limits the downstream effects of histamine activity, such as increased capillary permeability and the stimulation of sensory nerves responsible for hypersensitivity reflexes.


Dual-Pathway Physiological Modulation

The overall function is defined by the complementary co-action of these two distinct mechanistic domains: vascular constriction and histamine blockade. The combination effects simultaneous modulation across different physiological systems—the sympathetic (vascular) pathway and the inflammatory signaling pathway. This dual intervention results in a combined physiological modulation across the sympathetic and inflammatory systems.

Dosage and Administration Information

How to Use Neo Protifed

Neo Protifed, a combination of triprolidine and pseudoephedrine, is administered exclusively through the oral route. It is supplied in two primary forms: a standard-release oral tablet and an oral liquid or syrup. The typical adult strength of the tablet is 2.5 mg of triprolidine and 60 mg of pseudoephedrine.


Official Dosing and Frequency

Usage of this medicine is designated as short-term and administered on an as-needed basis for temporary symptomatic management.

Category Standard Adult Regimen (12 years) Constraint
Dose Quantity One tablet (2.5 mg/60 mg) or 10 mL of liquid N/A
Dose Interval Every 4 to 6 hours N/A
Maximum Daily Limit N/A 4 doses in 24 hours

Administration and Procedural Rules

Official instructions specify that the dose may be taken with or without food. When administering the liquid form, a specialized measuring device must be used to ensure the correct volume is given, as common household spoons may be inaccurate. The 2.5 mg/60 mg tablet strength is generally not approved for use in children under 12 years of age. If a scheduled dose is missed, patients should skip the missed dose and take the next dose at the regularly planned time; doses must not be doubled to compensate.

Recent Clinical Evidence

Research evidence / Overview of studies for Neo Protifed

Evidence for Use in Allergic Rhinitis and Hay Fever

The research base for this medication includes short-term, placebo-controlled Randomized Controlled Trials (RCTs). These studies were used in research exploring how symptoms change over time when managing conditions characterized by fluctuating or episodic manifestations, such as hay fever and allergic rhinitis. The populations studied were mainly adults who had confirmed allergies and met specific criteria for symptom severity.

The findings from these trials contributed to the body of evidence describing how symptoms were measured and recorded during the study period. Reports described patterns where measurements of nasal obstruction in the group receiving the decongestant component differed from those receiving placebo. Similarly, research findings described patterns in the measured outcomes related to irritative states like sneezing and itching in the group receiving the antihistamine component. The data primarily focused on short-term symptom changes measured within hours of administration.

Evidence for Use in the Common Cold

Research has explored this combination in individuals experiencing conditions characterized by symptoms of the common cold, a non-allergic condition associated with acute or disruptive episodes. Research here includes Randomized Controlled Trials and subsequent Systematic Reviews that focused on the study design and outcomes used to evaluate changes in the severity of stuffy nose, runny nose, and sneezing. These studies were conducted during periods of increased symptom activity in populations of healthy adults and older children (e.g., ages 6 to 11).

Findings described patterns in the measured outcomes related to nasal obstruction/stuffiness for the decongestant component. Data show patterns related to symptom change that were mixed or inconsistent across all individual cold symptoms. Overall, the studies contribute to the broader evidence landscape by monitoring temporary physiological imbalance, but results apply only to the populations studied.

Long-Term Research and Follow-up Durations

The available research describes short-term changes in symptom patterns. The follow-up durations in the clinical trials were typically limited, focusing on the temporary nature of episodic symptoms. Long-term effects are not fully established, and research is ongoing to help show what has been observed so far with sustained use.

What Remains Uncertain About the Research Base

There are identifiable gaps in the evidence base. Comparative evidence is lacking to definitively understand how this combination drug compares against newer formulations that are currently available. The reliance on patient-reported outcomes describing perceived discomfort in many trials means that results are often subjective. Overall, the research highlights what is known—and what is still uncertain—about this medicine’s place in the evidence landscape.

Key Studies & References Effectiveness of an antihistamine-decongestant combination for young children with the common cold: A randomized, controlled clinical trial (Study on young children/evidence gap)

Frequently Asked Questions (FAQ)

Common questions about Neo Protifed (FAQ)

Q: What is the main difference between Neo Protifed and other medicines for the same condition?

A: Neo Protifed is a fixed-dose combination medication containing both a nasal decongestant and an antihistamine. This dual composition is intended to simultaneously address two distinct symptom pathways: the congestion from swollen blood vessels and the allergic reactions caused by histamine. Official product information indicates this combined approach is intended to modulate symptoms across different physiological systems compared to treatments with only one active ingredient.

Q: Why is Neo Protifed prescribed instead of older medications?

A: The dual-action of its ingredients, Pseudoephedrine and Triprolidine, is the basis for its utility. Official information describes the drug’s function as modulating two distinct symptom pathways simultaneously: vasoconstriction (reducing swelling) and H1-receptor blockade (reducing allergic response). This complementary action is intended to provide temporary relief across multiple common symptoms.

Q: How quickly should I expect to notice the intended effects of Neo Protifed?

A: Studies examining the decongestant component, Pseudoephedrine, generally report that the onset of action (the time when measurable effects begin) is typically observed within approximately 30 minutes after administration. This finding helps describe the time frame in which the decongestant effects may begin.

Q: Does Neo Protifed start working right away, or does it take time to build up in the body?

A: Official product information describes this medicine as being for short-term, temporary relief, meaning it is not generally intended to be taken long-term to build up to a steady state in the body. The combination is associated with a relatively quick onset of action, consistent with temporary relief.

Q: What happens if I stop taking Neo Protifed suddenly?

A: Since this medicine is designated for short-term, as-needed use to manage temporary symptoms, regulatory documents do not describe a recognized withdrawal syndrome associated with abrupt cessation. The absence of a documented withdrawal syndrome is consistent with its designation for short-term, temporary use.

Q: Is Neo Protifed safe to take long-term, for years?

A: Neo Protifed is officially administered only for the short-term management of temporary symptoms, and long-term effects are not fully established. Regulatory warnings associated with the decongestant component advise that continued use carries risks such as the development of tolerance and possible Central Nervous System (CNS) effects. Official regulatory guidance generally advises that this type of medication be used for the shortest duration possible.

Q: Is a metallic taste in the mouth normal when first starting Neo Protifed?

A: While a metallic taste is not specifically listed as a common side effect in the official safety documents, the official safety information notes that certain taste disorders or disturbances have been reported as adverse effects of medicines in this class. Other common oral effects, such as dry mouth, are documented.

Q: Is there a way to reduce the common side effects of Neo Protifed?

A: General patient information suggests that taking the medicine with food or a snack has been reported to help some users with nausea, and chewing sugar-free gum may help manage dry mouth. Official information advises caution, but does not provide specific medical instruction on reducing side effects.

Q: Can Neo Protifed affect my ability to drive or operate machinery?

A: Official labeling includes a specific warning that drowsiness may occur and caution should be used when driving or operating machinery. This is due to the antihistamine component (Triprolidine), which may cause Central Nervous System (CNS) depression.

Q: Does Neo Protifed interact with standard over-the-counter pain relievers like ibuprofen?

A: Official documents do not list a specific major interaction between this combination drug and standard non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or acetaminophen. However, the labeling advises checking the contents of any other cold or flu remedies taken simultaneously to minimize the potential for accidental overdose of any single ingredient.

Q: What is the risk of a serious interaction with herbal supplements while taking Neo Protifed?

A: Official regulatory bodies generally advise that there is often not enough information available to definitively determine if many herbal remedies and supplements have documented interaction patterns with this medicine. For this reason, official sources generally advise caution when combining this drug with untested substances.

Q: Is Neo Protifed safe for people over the age of 65?

A: Official labeling notes that older adults may be more susceptible to certain adverse effects. These include an increased susceptibility to dizziness, drowsiness, confusion, and urinary problems. Due to the presence of a first-generation antihistamine, certain medical guidelines cite this component as a consideration for use in this population group.

Q: Are there special considerations for children who might need Neo Protifed?

A: Special considerations are defined by official age restrictions, where the standard tablet strength is not approved for use in children under 12 years of age. For the liquid form, a specialized measuring device is required for proper administration, as detailed in the official instructions. It is also noted that the antihistamine component may cause excitation in some young children.

Q: Is a history of heart issues a reason to avoid Neo Protifed?

A: Official regulatory labeling contains precaution statements regarding the use of this product for individuals with pre-existing conditions such as high blood pressure (hypertension) or heart disease. The decongestant component, Pseudoephedrine, is associated with the potential for cardiac stimulation and is formally contraindicated in severe or uncontrolled hypertension.

Q: Where can I find the official regulatory document (like the FDA label or SmPC) for Neo Protifed?

A: A comprehensive search of major government databases did not identify an official regulatory record for the product name Neo Protifed. As a result, no official prescribing label or Summary of Product Characteristics (SmPC) has been formally documented for this specific name in major regulatory databases. Official documents for the active ingredients (Pseudoephedrine and Triprolidine) are available.

Q: Is Neo Protifed a controlled substance or scheduled drug?

A: The combination drug is generally not listed as a Controlled Substance by the DEA. However, the active component Pseudoephedrine is a regulated chemical under the Combat Methamphetamine Epidemic Act (CMEA), which imposes restrictions on the retail sale and purchase quantity of the drug.

Q: Is it better to take Neo Protifed in the morning or at night?

A: Regulatory information notes that the drug can be taken with or without food and does not specify a time of day. Since official safety information lists both drowsiness (somnolence) and, less commonly, difficulty sleeping (insomnia) as possible effects, the timing of the dose may be considered in relation to a person's daily activity or sleep schedule.

Q: Why is the drug required to be taken with a specific amount of fluid?

A: Official instructions state that the dose may be taken with or without food. There is no regulatory requirement in the official documents specifying that the tablet must be taken with a specific, measured amount of fluid.

Q: Are there different brand names for the medicine Neo Protifed?

A: While the specific name 'Neo Protifed' is not listed in regulatory databases, the chemical combination of its two active ingredients, Pseudoephedrine and Triprolidine, is a widely recognized formulation. This combination is marketed globally under various different brand names.

Q: What are the signs that Neo Protifed might not be working for someone?

A: The regulatory labeling specifies that if symptoms do not show improvement within 7 days or if they worsen or are accompanied by a fever, use should be stopped. These conditions are regulatory indicators that the medicine may not be providing the intended symptomatic relief.

Q: What is the difference between the 'on-label' use and how some people discuss it online?

A: Regulatory agencies define the approved (on-label) use as the temporary relief of symptoms associated with hay fever, allergic rhinitis, or the common cold. The official labeled indications do not include discussions about other conditions or uses that may be found online.

Q: Can Neo Protifed affect mood or cause emotional changes?

A: Official safety information lists potential effects on the nervous system. These include commonly reported issues like drowsiness and, less frequently, side effects such as confusion, nervousness, and excitability (particularly in children). Serious, rare effects on the central nervous system have also been documented in regulatory labels.

Q: How long does Neo Protifed stay in your system after the last dose?

A: Official product information describes the rate at which the drug is cleared from the system using the elimination half-life. For the decongestant component (Pseudoephedrine), this half-life is reported as approximately 5.4 hours.

Q: What level of evidence (Phase 3 data, etc.) supports the claims for Neo Protifed?

A: The evidence supporting the claims for this medicine is primarily derived from short-term, placebo-controlled Randomized Controlled Trials (RCTs) and subsequent Systematic Reviews. This research contributed to the body of evidence describing temporary symptom changes over short periods, consistent with the standard research for over-the-counter respiratory medications.

Q: Why do official sources recommend a certain frequency for monitoring blood pressure while on Neo Protifed?

A: The decongestant component, Pseudoephedrine, is associated with documented cardiovascular risks and should not be used in cases of severe or uncontrolled high blood pressure. While not mandatory for all, some official health guidelines note the importance of regular blood pressure monitoring for individuals who use the medicine for extended periods due to these potential effects.

Q: Can Neo Protifed cause insomnia or affect sleep patterns?

A: Official warnings state that sleeplessness (insomnia) and nervousness are possible side effects associated with this medication. These effects are listed as regulatory indicators that, if they occur, consulting a healthcare professional is necessary.

Q: Does the efficacy of Neo Protifed change over time?

A: Regulatory warnings state that with continued use of the decongestant component (Pseudoephedrine), a phenomenon called tolerance may develop. Tolerance is a description of how the body can adjust to the medicine over time, which is an observation that may be associated with a decrease in the decongestant effect.

Q: What does the eligibility criteria 'contraindication' mean for Neo Protifed?

A: A contraindication is a formal, official statement found in regulatory labeling that describes a specific medical condition or circumstance where the product is strictly advised against. This is because the potential risks of use are officially determined to outweigh any potential benefits or could cause serious harm.

How should Neo Protifed be stored and disposed of?

Storage and Disposal of Neo Protifed

Neo Protifed must be stored strictly according to the conditions listed on the official regulatory label to maintain its stability and effectiveness. The product should be kept at Controlled Room Temperature, which is generally between 20°C and 25°C (68°F and 77°F). It is mandatory to protect the medicine from both light and moisture.

Handling and Stability

Do not refrigerate or freeze Neo Protifed. Keep the product in its original, tightly closed container and utilize the child-resistant packaging. If the container is opened, any unused portion must be discarded after 60 days.

Disposal Requirements

Disposal must comply with environmental regulations. Do not flush unused or expired Neo Protifed down the toilet or place it in household trash. Instead, dispose of the medicine using an approved pharmaceutical take-back program or official collection site.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Neo Protifed found in:

A-Z Index: